Retraction notice to "Vascular endothelial growth factor (VEGF) delivery approaches in regenerative medicine" [Biomedicine & Pharmacotherapy 166 (2023) 115301] - 19/07/26
Doi : 10.1016/j.biopha.2026.119694
Nima Beheshtizadeh a, c, ⁎, Maliheh Gharibshahian b, c, Mohammad Bayati d, Reza Maleki e, ⁎, Hannah Strachan f, Sarah Doughty f, Lobat Tayebi f
a Department of Tissue Engineering, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Iran
b Department of Tissue Engineering, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran
c Regenerative Medicine group (REMED), Universal Scientific Education and Research Network (USERN), Tehran, Iran
d Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran
e Department of Chemical Technologies, Iranian Research Organization for Science and Technology (IROST), P.O. Box 33535111, Tehran, Iran
f Marquette University School of Dentistry, Milwaukee, WI 53233, USA
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 201
Article 119694- août 2026 Retour au numéro
Article précédent
- Retraction notice to "Molecular insights into experimental models and therapeutics for cholestasis" [Biomedicine & Pharmacotherapy 174 (2024) 116594]
- Wenwen Zhang, Hefei Wu, Shiman Luo, Xiaohua Lu, Xiyue Tan, Li Wen, Xiao Ma, Thomas Efferth
- Expression of concern: “Design and synthesis of benzo[d]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson's disease" [Biomed. Pharmacother. 156 (2022) 113838]
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?